Korean Journal of Anesthesiology

The Korean Society of Anesthesiologists (대한마취통증의학회)
권호 표지

A Comparison of the Therapeutic Effects of Hyaluronic Acid and Triamcinolone Used in an Intra-articular Injection for Knee Osteoarthritis

무릎골관절염 치료를 위한 Hyaluronic Acid와 Triamcinolone 주입 효과 비교

Song, Sun-Ok;Chang, Young-Jun
송선옥;장영준

  • Published : 20041000
⟨ Previous Next ⟩

Abstract

Background: Both steroid and hyaluronic acid (HA) are effective therapeutic regimens when used as intra-articular (IA) injections for knee osteoarthritis. This study was performed to re-estimate the hypothesis that the IA injection of HA is more effective than that of steroid. Methods: A retrospective study was conducted by reviewing the medical records of osteoarthritis of the knee patients treated only by IA injection with HA or triamcinolone (Triam) at our pain clinic over the last 28 months. The HA group (N = 17) received an IA injection of 25 mg of HA followed by a 5 ml injection of 1% lidocaine once a week for 5 weeks. The triam group (N = 34) received an IA injection of a mixed solution of 5-10 mg of triamcinolone and 6-8 ml of 1% lidocaine 3 to 5 times at one or two week intervals. Pain improvement was compared using pain relief scale (PRS) scores at the end of a series of IA injections in each patient. Results: Both groups showed significant pain improvement following a series of IA injection, compared to the pre-treatment pain state; mean PRS post-injections was 5.1 $\pm$ 2.6 in the HA group and 6.1 $\pm$ 2.9 in the Triam group (P < 0.05 for both). However, there were no significant differences between the groups. Conclusions: Our results suggest that IA injections with either HA or triamcinolone are effective in knee osteoarthritis. No significant difference was found between Triam and HA use in IA injections for knee osteoarthritis.

Keywords

References

  1. Vad VB, Bhat AL, Sculco TP, Wickiewicz TL: Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone. Arch Phys Med Rehabil 2003; 84: 634-7
  2. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al: Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995; 38: 1541-6
  3. Hochberg MC, Perlmutter DL, Hudson JI, Altman RD: Preferences in the management of osteoarthritis of the hip and knee: results of a survey of community-based rheumatologists in the United States. Arthritis Care Res 1996; 9: 170-6 https://doi.org/10.1002/1529-0131(199606)9:3<170::AID-ANR1790090304>3.0.CO;2-K
  4. Sambrook PN, Champion GD, Browne CD, Cairns D, Cohen ML, Day RO, et al: Corticosteroid injection for osteoarthritis of the knee: peripatellar compared to intra-articular route. Clin Exp Rheumatol 1989; 7: 609-13
  5. Jones A, Doherty M: Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996; 55: 829-32 https://doi.org/10.1136/ard.55.11.829
  6. Creamer P: Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 1999; 11: 417-21 https://doi.org/10.1097/00002281-199909000-00016
  7. Leardini G, Mattara L, Franceschini M, Perbellini A: Intraarticular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 1991; 9: 375-81
  8. Huskisson EC, Donnelly S: Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 1999; 38: 602-7 https://doi.org/10.1093/rheumatology/38.7.602
  9. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, et al: The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995; 3: 213-25 https://doi.org/10.1016/S1063-4584(05)80013-5
  10. Altman RD, Moskowitz R: Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998; 25: 2203-12
  11. Waddell DD, Cefalu CA, Bricker DC: An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 2003; 19: 499-507 https://doi.org/10.1185/030079903125002090
  12. Leardini G, Mattara L, Franceschini M, Perbellini A: Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 1991; 9: 375-81
  13. Forster MC, Straw R: A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee 2003; 10: 291-3 https://doi.org/10.1016/S0968-0160(02)00145-X
  14. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, et al: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997; 5: 153-60 https://doi.org/10.1016/S1063-4584(97)80010-6
  15. Tamir E, Robinson D, Koren R, Agar G, Halperin N: Intraarticular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001; 19: 265-70 https://doi.org/10.1007/s100510170335
  16. Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001; 44: 1237-47 https://doi.org/10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F
  17. Smith MD, Wetherall M, Darby T, Esterman A, Slavotinek J, Roberts-Thomson P, et al: A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee. Rheumatology (Oxford) 2003; 42: 1477-85 https://doi.org/10.1093/rheumatology/keg398
  18. Creamer P, Hunt M, Dieppe P: Pain mechanisms in osteoarthritis of the knee: effect of intraarticular anesthetic. J Rheumatol 1996; 23: 1031-6
  19. Balazs EA, Watson D, Duff IF, Roseman S: Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967; 10: 357-76 https://doi.org/10.1002/art.1780100407
  20. Jones AC, Pattrick M, Doherty S, Doherty M: Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 1995; 3: 269-73 https://doi.org/10.1016/S1063-4584(05)80018-4
  21. Tascioglu F, Oner C: Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 2003; 22: 112-7 https://doi.org/10.1007/s10067-002-0690-1
  22. Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S: Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 2003; 85-A: 1197-203
  23. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R: Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996; 23: 1579-85
  24. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004; 86-A: 538-45
  25. Hashizume K: Clinical experience of pain management for the osteoarthritis of knee: an analysis of 134 cases. Pain Clinic 2003; 3: 726-34
  26. Creamer P, Lethbridge-Cejku M, Hochberg MC: Determinants of pain severity in knee osteoarthritis: effect of demographic and psychosocial variables using 3 pain measures. J Rheumatol 1999: 26: 1785-92
  27. Wall PD: New horizons: an essay. In: Neural blockade in clinical anesthesia and management of pain. 3rd ed. Edited by Cousins MJ, Bridenbaugh PO: Philadelphia, Lippincott-Raven Publishers. 1998, p 1138
  28. Doherty MM, Hughes PJ, Korszniak NV, Charman WN: Prolongation of lidocaine-induced epidural anesthesia by medium molecular weight hyaluronic acid formulations: pharmacodynamic and pharmacokinetic studies in the rabbit. Anesth Analg 1995; 80: 740-6 https://doi.org/10.1097/00000539-199504000-00016
  29. Doherty MM, Hughes PJ, Charman SA, Brock KV, Korszniak NV, Charman WN: Biphasic drug absorption from the epidural space of the dog may limit the utility of a slow release medium molecular weight hyaluronic acid-lidocaine ionic complex formulation. Anesth Analg 1996; 83: 1244-50 https://doi.org/10.1097/00000539-199612000-00020
  30. Johansson A, Hassan H, Renck H: Effects of adjuvants to local anaesthetics on their duration. IV. Effect of hyaluronic acid added to bupivacaine or prilocaine on the duration of nerve blockade in man. Acta Anaesthesiol Scand 1985; 29: 736-8 https://doi.org/10.1111/j.1399-6576.1985.tb02291.x